Ghost Tree Capital’s ResMed RMD Stock Holding History

Ghost Tree Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$2.89M	–	77
2016 Q1	$2.89M	Buy	+50,000	New	+$2.83M	1.64%	24

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Ghost Tree Capital's RMD Position: Q2 2016 in Review

Ghost Tree Capital sold out of ResMed (RMD) in Q2 2016, closing a stake of 50,000 shares — an estimated $2.89M sold.

Ghost Tree Capital first reported a position in RMD in Q1 2016 and held it in 1 quarter. The position peaked at $2.89M in Q1 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q2 2016.

Ghost Tree Capital reported no remaining ResMed position as of Q2 2016 after selling out during the quarter.
Ghost Tree Capital sold 50,000 ResMed shares in Q2 2016, an estimated $2.89M.
Ghost Tree Capital first reported a position in ResMed in Q1 2016 and held it in 1 quarter.
Ghost Tree Capital's ResMed position peaked at $2.89M in Q1 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q2 2016.

Based on Ghost Tree Capital's 13F filing for Q2 2016, filed 12 Aug 2016.